HCPCS Code Section: HCPCS Q Codes

Q3028

Injection, interferon beta-1a, 1 mcg for subcutaneous use Short Description: Inj beta interferon sq 1 mcg Coverage Code: Not payable by Medicare Action Code: No maintenance for this code …

Q3027

Injection, interferon beta-1a, 1 mcg for intramuscular use Short Description: Inj beta interferon im 1 mcg Coverage Code: Special coverage instructions apply Action Code: No maintenance for this code …

Q3014

Telehealth originating site facility fee Short Description: Telehealth facility fee Coverage Code: Carrier judgment Action Code: No maintenance for this code Date Added: October 1, 2001 Effective Date: October …

Q3001

Radioelements for brachytherapy, any type, each Short Description: Brachytherapy radioelements Coverage Code: Special coverage instructions apply Action Code: No maintenance for this code Date Added: July 1, 2000 Effective …

Q2052

Services, supplies and accessories used in the home under the medicare intravenous immune globulin (ivig) demonstration Short Description: Ivig demo, services/supplies Coverage Code: Special coverage instructions apply Action Code: …

Q2050

Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg Short Description: Doxorubicin inj 10mg Coverage Code: Special coverage instructions apply Action Code: No maintenance for this code Date Added: …

Q2049

Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg Short Description: Imported lipodox inj Coverage Code: Carrier judgment Action Code: No maintenance for this code Date Added: July 1, 2012 …

Q2043

Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion Short Description: Sipuleucel-t auto cd54+ Coverage Code: Special coverage …

Q2042

Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Short Description: Tisagenlecleucel car-pos t Coverage Code: Carrier judgment Action Code: …

Q2041

Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Short Description: Axicabtagene ciloleucel car+ Coverage Code: …